Selenite (Sodium) / LC3I Cancer Research Results

SSE, Selenite (Sodium): Click to Expand ⟱

Features:

Sodium Selenite - is inorganic selenium in the selenite oxidation state (Se⁴⁺)
Sodium selenite is produced industrially from selenium metal, which itself is obtained as a by-product of copper refining.

Mechanistic distinction from Selenium:
-Selenite reacts with GSH → GS–Se–SG intermediates
-Generates superoxide, H₂O₂
-Exploits cancer cells’ elevated basal oxidative stress
-Normal cells neutralize it more effectively (higher redox reserve)

Both the uptake and processing of selenium has recently shown to be upregulated in subsets of cancer cells
 due to their increased expression of xCT transporter
The more a tumor depends on xCT, the more toxic selenite becomes. High xCT Also Increases SSE Toxicity. High xCT increases intracellular thiols, which increases SSE chemical trapping, redox cycling, and cytotoxic impact.

Sodium selenite might protect against toxicity of AgNPs. also here

SSE and cancer

Rank	Pathway / Target Axis	Direction	Primary Effect	Notes / Cancer Relevance	Ref
1	Redox cycling with thiols (superoxide generation)	↑ O2•− / ↑ ROS	Acute oxidative stress	Defines sodium selenite anticancer mechanism in many models: early superoxide rise precedes mitochondrial apoptotic events	(ref)
2	Glutathione buffering (GSH pool)	↓ GSH	Loss of redox buffering	Work in hepatoma models demonstrates GSH’s key role in selenite-driven oxidative stress and apoptosis	(ref)
3	Mitochondrial integrity (ΔΨm)	↓ ΔΨm	Mitochondrial dysfunction	Sequential mechanism shown: superoxide rise → mitochondrial depolarization	(ref)
4	Intrinsic apoptosis (cytochrome c → Caspase-9/3)	↑ cytochrome c release / ↑ Caspase-9/3	Programmed cell death	Same sequential model shows cytochrome c release followed by caspase-9 and caspase-3 activation	(ref)
5	ER stress / UPR (PERK → eIF2α → ATF4)	↑ PERK/eIF2α/ATF4	Proteotoxic stress signaling	ER-stress module is shown as a core driver in selenite-induced autophagy→apoptosis progression	(ref)
6	Stress MAPK (p38) as switch control	↑ p38 activation	Signal switching (autophagy → apoptosis)	Mechanistic evidence for p38 participating in the selenite-driven transition toward apoptosis	(ref)
7	p53 activation (stress response)	↑ p53 phosphorylation (Ser15)	Facilitates apoptosis programs	NB4 leukemia model: selenite induces p53 Ser15 phosphorylation via p38/ERK in the autophagy–apoptosis switch context	(ref)
8	DNA damage response (ATM-dependent signaling)	↑ ATM-dependent DDR	Checkpoint activation & death signaling	Selenium compounds (including selenite contexts) activate ATM-dependent DNA damage response signaling in colorectal cancer models	(ref)
9	PI3K–AKT axis linked to autophagy/apoptosis balance	↓ PI3K/Akt (functional axis) / ↓ protective autophagy	Apoptosis sensitization	NB4 leukemia: sodium selenite increases apoptosis by autophagy inhibition through PI3K/Akt	(ref)
10	NF-κB signaling	↓ NF-κB	Reduced anti-apoptotic transcription	Mechanistic study: sodium selenite induces ROS-mediated inhibition of NF-κB with downstream shift toward apoptosis	(ref)
11	Angiogenesis signaling (VEGF)	↓ VEGF expression	Reduced vascular support signals	Prostate cancer PC3 model: sodium selenite inhibits expression of VEGF (and related inflammatory/pro-growth factors) in the tested context	(ref)
12	Ferroptosis (iron-dependent oxidative death)	↑ ferroptosis	Non-apoptotic oxidative death modality	Paper explicitly reports sodium selenite as an inducer of ferroptosis across multiple human cancer cell types	(ref)

Table to compare Sodium Selenite to SeNPs
-Sodium selenite → chemical oxidant (thiol attack → ROS shock).
-SeNPs → engineered redox stressor (signaling-level control, broader window).
-Selenomethionine / Se-yeast → redox buffer & selenium storage form (often protective to cancer cells, especially when oxidative stress is a therapeutic goal).

Dimension	Sodium Selenite (Na2SeO3)	Selenium Nanoparticles (SeNPs)	Selenomethionine / Se-Yeast
Primary mechanistic class	Direct redox-disrupting agent	Controlled redox modulator / signaling perturbator	Nutritional selenium reservoir / selenoprotein precursor
Initial molecular interaction	Rapid reaction with cellular thiols (GSH, Trx, protein –SH)	Cellular uptake → gradual selenium release or surface redox effects	Nonspecific incorporation into proteins in place of methionine
ROS generation	↑↑ acute, non-buffered ROS burst	↑ mild–moderate, sustained ROS	↓ or ↔ (antioxidant bias)
Glutathione (GSH) system	↓↓ GSH depletion	↔ or mild ↓ (context-dependent)	↑ GSH recycling via GPX support
Redox selectivity (cancer vs normal)	Limited; toxicity threshold close to efficacy	Improved tumor selectivity window	Poor for cancer killing; favors normal-cell protection
Mitochondrial integrity (ΔΨm)	↓↓ rapid depolarization	↓ gradual, dose-dependent disruption	↔ or ↑ mitochondrial protection
Dominant cell-death pathways	Intrinsic apoptosis ± necrosis (high dose)	Apoptosis ± ferroptosis ± autophagy-related death	None (cytoprotective)
ER stress / UPR (PERK–CHOP)	↑ strong, early activation	↑ moderate, delayed activation	↓ ER stress via antioxidant capacity
DNA damage response	↑ oxidative DNA lesions (ATM/ATR)	↑ low–moderate, secondary to ROS	↓ DNA damage; improved repair environment
PI3K–AKT survival signaling	↓ secondary to oxidative collapse	↓ reported in multiple tumor models	↔ or ↑ survival signaling
NF-κB / inflammatory signaling	↓ via redox inhibition	↓ selectively; anti-inflammatory bias	↓ chronic inflammation (protective)
Ferroptosis involvement	Minor / indirect	↑ lipid peroxidation; GPX4 modulation	↓↓ ferroptosis risk (GPX4 support)
Autophagy	↑ early (protective) → collapse	↑ contributory to tumor suppression	↔ homeostatic maintenance
Angiogenesis (VEGF)	↓ at cytotoxic doses	↓ at lower, tolerated doses	↔ or mild ↓ (indirect)
Immune compatibility	Poor at anticancer doses	Moderate–good; often immune-supportive	High; supports immune competence
Pharmacologic control	Poor (steep dose–toxicity curve)	High (size, coating, release tunable)	Low (slow turnover, storage form)
Normal tissue tolerance	Low	Moderate–high	High
Overall cancer relevance	Potent but hazardous cytotoxic agent	Balanced anticancer redox modulator	Generally counterproductive for direct cancer killing
Overall therapeutic profile	Potent but narrow safety margin	Lower acute potency, broader usable window

LC3I, Lysosomal-associated membrane protein 2A: Click to Expand ⟱

Source:

Type:

LC3I (Lysosomal-associated membrane protein 2A, also known as LAMP2A) is a protein that plays a crucial role in the process of chaperone-mediated autophagy (CMA). CMA is a type of autophagy, a cellular process in which cells recycle and remove damaged or dysfunctional components.
LC3I is overexpressed in certain types of cancer, including breast, lung, and colon cancer.
The conversion of LC3-I to LC3-II (the lipidated form) is a key step in autophagy activation.

: In many cancers, low levels of LC3-I may indicate impaired autophagy, which can lead to the accumulation of damaged proteins and organelles, contributing to tumorigenesis. This is often associated with poor prognosis.
Tumor Promoting Role: In some contexts, the presence of LC3-I may indicate a baseline level of autophagy that is necessary for cellular homeostasis, but its role is less prominent compared to LC3-II.
Generally, decreased expression of LC3-I is associated with worse prognosis in many cancers, indicating its potential role in tumor suppression through the regulation of autophagy. However, the context-dependent nature of LC3-I's function suggests that further research is needed to fully understand its roles in different cancer types and its potential as a therapeutic target.

Scientific Papers found: Click to Expand⟱

5108-

SSE,

Activation of p53 by sodium selenite switched human leukemia NB4 cells from autophagy to apoptosis

in-vitro,

AML,

U937

p‑P53↑, Beclin-1↓, LC3I↓, Apoptosis↑, Casp↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Cell Death ⓘ

Apoptosis↑, 1, Casp↑, 1,

Autophagy & Lysosomes ⓘ

Beclin-1↓, 1, LC3I↓, 1,

DNA Damage & Repair ⓘ

p‑P53↑, 1,
Total Targets: 5

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: LC3I, Lysosomal-associated membrane protein 2A

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells